SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000912057-02-011869
Filing Date
2002-03-27
Accepted
2002-03-27 00:00:00
Documents
6
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2073956z10-k.htm 10-K 469715
3 EXHIBIT 4.2 a2073956zex-4_2.txt EX-4.2 5205
4 EXHIBIT 10.9 a2073956zex-10_9.txt EX-10.9 2301
5 EXHIBIT 10.17 a2073956zex-10_17.txt EX-10.17 51100
6 EXHIBIT 10.18 a2073956zex-10_18.txt EX-10.18 1289
7 EXHIBIT 23 a2073956zex-23.txt EX-23 721
  Complete submission text file 0000912057-02-011869.txt   532463
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-15006 | Film No.: 02588180
SIC: 2835 In Vitro & In Vivo Diagnostic Substances